Mithra is Meeting U.S. Institutional Investors at J.P. Morgan Conference

Liège, Belgium – Mithra Pharmaceuticals, leader in Women’s Health and cutting-edge technological company in the field of API slow-release drugs based on polymere (subcutaneous implants, biocompatible rings, hormonal IUD’s),announced today its participation to the 34th edition of the annual J.P. Morgan Healthcare Conference which is held from 11 to 15 January 2016 in San Francisco.

Read the Press Release